Fairvalue-Calculator Fairvalue-Calculator
EN DE

GridAI Technologies Corp (GRDX) Fair Value & Analysis

Healthcare · US · Market cap $36.0M

Price$4.60
Fair Value$6.40
Upside+39.1%
Quality80/100
Evidence: Low Range $4.80 – $8.01

Fair value as of: Jun 24, 2026

Analysis

GridAI Technologies Corp (GRDX) currently trades at $4.60, while our model-based Fair Value estimate is $6.40 — implying the stock looks roughly 39.1% undervalued today. We read business quality at 80/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -88% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -27% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +9% Alnylam Pharmaceuticals, Inc (ALNY) -62%

Frequently asked questions

Is GridAI Technologies Corp (GRDX) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $6.40 versus a price of $4.60 — about +39% (undervalued). Model-based estimate, not financial advice.
What is the fair value of GRDX?
Our 21-model fair value for GridAI Technologies Corp is $6.40 (as of Jun 24, 2026), built from audited fundamentals. The current price is $4.60.
What is the quality score of GRDX?
GridAI Technologies Corp has a Quality Score of 80/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.